Cargando…

A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins

Histone post-translational modifications (PTMs) contribute to chromatin accessibility due to their chemical properties and their ability to recruit enzymes responsible for DNA readout and chromatin remodeling. To date, more than 400 different histone PTMs and thousands of combinations of PTMs have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidoli, Simone, Lopes, Mariana, Lund, Peder J., Goldman, Naomi, Fasolino, Maria, Coradin, Mariel, Kulej, Katarzyna, Bhanu, Natarajan V., Vahedi, Golnaz, Garcia, Benjamin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754405/
https://www.ncbi.nlm.nih.gov/pubmed/31541121
http://dx.doi.org/10.1038/s41598-019-49894-4
_version_ 1783453069131907072
author Sidoli, Simone
Lopes, Mariana
Lund, Peder J.
Goldman, Naomi
Fasolino, Maria
Coradin, Mariel
Kulej, Katarzyna
Bhanu, Natarajan V.
Vahedi, Golnaz
Garcia, Benjamin A.
author_facet Sidoli, Simone
Lopes, Mariana
Lund, Peder J.
Goldman, Naomi
Fasolino, Maria
Coradin, Mariel
Kulej, Katarzyna
Bhanu, Natarajan V.
Vahedi, Golnaz
Garcia, Benjamin A.
author_sort Sidoli, Simone
collection PubMed
description Histone post-translational modifications (PTMs) contribute to chromatin accessibility due to their chemical properties and their ability to recruit enzymes responsible for DNA readout and chromatin remodeling. To date, more than 400 different histone PTMs and thousands of combinations of PTMs have been identified, the vast majority with still unknown biological function. Identification and quantification of histone PTMs has become routine in mass spectrometry (MS) but, since raising antibodies for each PTM in a study can be prohibitive, lots of potential is lost from MS datasets when uncharacterized PTMs are found to be significantly regulated. We developed an assay that uses metabolic labeling and MS to associate chromatin accessibility with histone PTMs and their combinations. The labeling is achieved by spiking in the cell media a 5x concentration of stable isotope labeled arginine and allow cells to grow for at least one cell cycle. We quantified the labeling incorporation of about 200 histone peptides with a proteomics workflow, and we confirmed that peptides carrying PTMs with extensively characterized roles in active transcription or gene silencing were in highly or poorly labeled forms, respectively. Data were further validated using next-generation sequencing to assess the transcription rate of chromatin regions modified with five selected PTMs. Furthermore, we quantified the labeling rate of peptides carrying co-existing PTMs, proving that this method is suitable for combinatorial PTMs. We focus on the abundant bivalent mark H3K27me3K36me2, showing that H3K27me3 dominantly represses histone swapping rate even in the presence of the more permissive PTM H3K36me2. Together, we envision this method will help to generate hypotheses regarding histone PTM functions and, potentially, elucidate the role of combinatorial histone codes.
format Online
Article
Text
id pubmed-6754405
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67544052019-10-02 A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins Sidoli, Simone Lopes, Mariana Lund, Peder J. Goldman, Naomi Fasolino, Maria Coradin, Mariel Kulej, Katarzyna Bhanu, Natarajan V. Vahedi, Golnaz Garcia, Benjamin A. Sci Rep Article Histone post-translational modifications (PTMs) contribute to chromatin accessibility due to their chemical properties and their ability to recruit enzymes responsible for DNA readout and chromatin remodeling. To date, more than 400 different histone PTMs and thousands of combinations of PTMs have been identified, the vast majority with still unknown biological function. Identification and quantification of histone PTMs has become routine in mass spectrometry (MS) but, since raising antibodies for each PTM in a study can be prohibitive, lots of potential is lost from MS datasets when uncharacterized PTMs are found to be significantly regulated. We developed an assay that uses metabolic labeling and MS to associate chromatin accessibility with histone PTMs and their combinations. The labeling is achieved by spiking in the cell media a 5x concentration of stable isotope labeled arginine and allow cells to grow for at least one cell cycle. We quantified the labeling incorporation of about 200 histone peptides with a proteomics workflow, and we confirmed that peptides carrying PTMs with extensively characterized roles in active transcription or gene silencing were in highly or poorly labeled forms, respectively. Data were further validated using next-generation sequencing to assess the transcription rate of chromatin regions modified with five selected PTMs. Furthermore, we quantified the labeling rate of peptides carrying co-existing PTMs, proving that this method is suitable for combinatorial PTMs. We focus on the abundant bivalent mark H3K27me3K36me2, showing that H3K27me3 dominantly represses histone swapping rate even in the presence of the more permissive PTM H3K36me2. Together, we envision this method will help to generate hypotheses regarding histone PTM functions and, potentially, elucidate the role of combinatorial histone codes. Nature Publishing Group UK 2019-09-20 /pmc/articles/PMC6754405/ /pubmed/31541121 http://dx.doi.org/10.1038/s41598-019-49894-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sidoli, Simone
Lopes, Mariana
Lund, Peder J.
Goldman, Naomi
Fasolino, Maria
Coradin, Mariel
Kulej, Katarzyna
Bhanu, Natarajan V.
Vahedi, Golnaz
Garcia, Benjamin A.
A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
title A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
title_full A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
title_fullStr A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
title_full_unstemmed A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
title_short A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
title_sort mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754405/
https://www.ncbi.nlm.nih.gov/pubmed/31541121
http://dx.doi.org/10.1038/s41598-019-49894-4
work_keys_str_mv AT sidolisimone amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT lopesmariana amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT lundpederj amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT goldmannaomi amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT fasolinomaria amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT coradinmariel amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT kulejkatarzyna amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT bhanunatarajanv amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT vahedigolnaz amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT garciabenjamina amassspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT sidolisimone massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT lopesmariana massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT lundpederj massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT goldmannaomi massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT fasolinomaria massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT coradinmariel massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT kulejkatarzyna massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT bhanunatarajanv massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT vahedigolnaz massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins
AT garciabenjamina massspectrometrybasedassayusingmetaboliclabelingtorapidlymonitorchromatinaccessibilityofmodifiedhistoneproteins